Dilation of human atria: Increased diffusion restrictions for ADP, overexpression of hexokinase 2 and its coupling to oxidative phosphorylation in cardiomyocytes

Mitochondrion

Volumn 13, Issue 5, 2013, Pages 399-409

  Roosimaa, Mart ^a   Põdramägi, Taavi ^a   Kadaja, Lumme ^a   Ruusalepp, Arno ^a   Paju, Kalju ^a   Puhke, Raivo ^a   Eimre, Margus ^a   Orlova, Ehte ^a   Piirsoo, Andres ^a   Peet, Nadežda ^a   Gellerich, Frank N ^a,b,c   Seppet, Enn ^a  

^a UNIVERSITY OF TARTU   (Estonia)

^b LEIBNIZ INSTITUTE FOR NEUROBIOLOGY   (Germany)

^c Leibniz Institute for Neurobiology ^*  (Germany)

Author keywords

Atrial dilation; Creatine kinase; Energy transfer; Hexokinase; Mitochondria

Indexed keywords

ADENOSINE DIPHOSPHATE; ADENOSINE PHOSPHATE; CREATINE KINASE; GLUCOSE; HEXOKINASE; LIPOFUSCIN; MESSENGER RNA; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE (UBIQUINONE);

ADULT; ARTICLE; AUTOPHAGY; CELL AGGREGATION; CONTROLLED STUDY; DIFFUSION; FEMALE; GENE; GENE OVEREXPRESSION; GLYCOLYSIS; HEART ATRIUM ENLARGEMENT; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HEART MUSCLE OXYGEN CONSUMPTION; HK2 GENE; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; MITOCHONDRIAL RESPIRATION; OXIDATIVE PHOSPHORYLATION; PRIORITY JOURNAL;

ATRIAL DILATION; CREATINE KINASE; ENERGY TRANSFER; HEXOKINASE; MITOCHONDRIA;

ADENOSINE DIPHOSPHATE; AGED, 80 AND OVER; CARDIOMYOPATHY, DILATED; FEMALE; HEXOKINASE; HUMANS; MALE; MIDDLE AGED; MITOCHONDRIA; MYOCYTES, CARDIAC; OXIDATIVE PHOSPHORYLATION;

EID: 84882893954     PISSN: 15677249     EISSN: 18728278     Source Type: Journal    
DOI: 10.1016/j.mito.2012.12.005     Document Type: Article

References (92)

1. Abhayaratna W.P., Seward J.B., Appleton C.P., Douglas P.S., Oh J.K., Tajik A.J., Tsang T.S.M. Left atrial size: physiologic determinants and clinical applications. J. Am. Coll. Cardiol. 2006, 47:2357-2363.
2. Aflalo C. Biologically localized firefly luciferase: a tool to study cellular processes. Int. Rev. Cytol. 1991, 130:269-323.
3. Aimé-Sempé C., Folliguet T., Rücker-Martin C., Krajewska M., Krajewska S., Heimburger M., Aubier M., Mercadier J.J., Reed J.C., Hatem S.N. Myocardial cell death in fibrillating and dilated human right atria. J. Am. Coll. Cardiol. 1999, 34:1577-1586.
4. Allessie M., Ausma J., Schotten U. Electrical, contractile and structural remodeling during atrial fibrillation. Cardiovasc. Res. 2002, 54:230-246.
5. Ananthakrishnan R., Moe G.W., Goldenthal M.J., Marín-García J. Akt signaling pathway in pacing-induced heart failure. Mol. Cell. Biochem. 2005, 268:103-110.
6. Anflous K., Veksler V., Mateo P., Samson F., Saks V., Ventura-Clapier R. Mitochondrial creatine kinase isoform expression does not correlate with its mode of action. Biochem. J. 1997, 322(Pt 1):73-78.
7. Anmann T., Eimre M., Kuznetsov A.V., Andrienko T., Kaambre T., Sikk P., Seppet E., Tiivel T., Vendelin M., Seppet E., Saks V.A. Calcium-induced contraction of sarcomeres changes the regulation of mitochondrial respiration in permeabilized cardiac cells. FEBS J. 2005, 272:3145-3161.
8. Ashrafian H., Frenneaux M.P., Opie L.H. Metabolic mechanisms in heart failure. Circulation 2007, 116:434-448.
9. Ausma J., Wijffels M., Thoné F., Wouters L., Allessie M., Borgers M. Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation 1997, 96:3157-3163.
10. Ausma J., Coumans W.A., Duimel H., Van der Vusse G.J., Allessie M.A., Borgers M. Atrial high energy phosphate content and mitochondrial enzyme activity during chronic atrial fibrillation. Cardiovasc. Res. 2000, 47:788-796.
11. Ausma J., Litjens N., Lenders M.H., Duimel H., Mast F., Wouters L., Ramaekers F., Allessie M., Borgers M. Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat. J. Mol. Cell. Cardiol. 2001, 33:2083-2094.
12. Baines C.P., Song C.-X., Zheng Y.-T., Wang G.-W., Zhang J., Wang O.-L., Guo Y., Bolli R., Cardwell E.M., Ping P. Protein kinase Cε interacts with and inhibits the permeability transition pore in cardiac mitochondria. Circ. Res. 2003, 92:873-880.
13. Barth A.S., Merk S., Arnoldi E., Zwermann L., Kloos P., Gebauer M., Steinmeyer K., Bleich M., Kääb S., Hinterseer M., Kartmann H., Kreuzer E., Dugas M., Steinbeck G., Nabauer M. Reprogramming of the human atrial transcriptome in permanent atrial fibrillation: expression of a ventricular-like genomic signature. Circ. Res. 2005, 96:1022-1029.
14. Belus A., Piroddi N., Ferrantini C., Tesi C., Cazorla O., Toniolo L., Drost M., Mearini G., Carrier L., Rossi A., Mugelli A., Cerbai E., van der Velden J., Poggesi C. Effects of chronic atrial fibrillation on active and passive force generation in human atrial myofibrils. Circ. Res. 2010, 107:144-152.
15. Bera A.K., Ghosh S., Das S. Mitochondrial VDAC can be phosphorylated by cyclic AMP-dependent protein kinase. Biochem. Biophys. Res. Commun. 1995, 209:213-217.
16. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72:248-254.
17. Burstein B., Nattel S. Atrial fibrosis: mechanisms and clinical relevance in atrial fibrillation. J. Am. Coll. Cardiol. 2008, 51:802-809.
18. Casaclang-Verzosa G., Gersh B.J., Tsang T.S.M. Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. J. Am. Coll. Cardiol. 2008, 51:1-11.
19. Cha Y.-M., Dzeja P.P., Shen W.K., Jahangir A., Hart C.Y.T., Terzic A., Redfield M.M. Failing atrial myocardium: energetic deficits accompany structural remodeling and electrical instability. Am. J. Physiol. Heart Circ. Physiol. 2003, 284:H1313-H1320.
20. Chen Y., Craigen W.J., Riley D.J. Nek1 regulates cell death and mitochondrial membrane permeability through phosphorylation of VDAC1. Cell Cycle 2009, 8:257-267.
21. Cheng W., Li B., Kajstura J., Li P., Wolin M.S., Sonnenblick E.H., Hintze T.H., Olivetti G., Anversa P. Stretch-induced programmed myocyte cell death. J. Clin. Invest. 1995, 96:2247-2259.
22. Conway M.A., Bottomley P.A., Ouwerkerk R., Radda G.K., Rajagopalan B. Mitral regurgitation: impaired systolic function, eccentric hypertrophy, and increased severity are linked to lower phosphocreatine/ATP ratios in humans. Circulation 1998, 97:1716-1723.
23. Corradi D., Callegari S., Maestri R., Benussi S., Alfieri O. Structural remodeling in atrial fibrillation. Nat. Clin. Pract. Cardiovasc. Med. 2008, 5:782-796.
24. De Jong A.M., Maass A.H., Oberdorf-Maass S.U., Van Veldhuisen D.J., Van Gilst W.H., Van Gelder I.C. Mechanisms of atrial structural changes caused by stretch occurring before and during early atrial fibrillation. Cardiovasc. Res. 2011, 89:754-765.
25. Dittrich H.C., Pearce L.A., Asinger R.W., McBride R., Webel R., Zabalgoitia M., Pennock G.D., Safford R.E., Rothbart R.M., Halperin J.L., Hart R.G. Left atrial diameter in nonvalvular atrial fibrillation: an echocardiographic study. Stroke prevention in atrial fibrillation investigators. Am. Heart J. 1999, 137:494-499.
26. Dzeja P.P., Terzic A. Phosphotransfer networks and cellular energetics. J. Exp. Biol. 2003, 206:2039-2047.
27. Dzeja P.P., Hoyer K., Tian R., Zhang S., Nemutlu E., Spindler M., Ingwall J.S. Rearrangement of energetic and substrate utilization networks compensate for chronic myocardial creatine kinase deficiency. J. Physiol. 2011, 589:5193-5211.
28. Eckstein J., Verheule S., de Groot N.M., de Groot N., Allessie M., Schotten U. Mechanisms of perpetuation of atrial fibrillation in chronically dilated atria. Prog. Biophys. Mol. Biol. 2008, 97:435-451.
29. Eimre M., Paju K., Pelloux S., Beraud N., Roosimaa M., Kadaja L., Gruno M., Peet N., Orlova E., Remmelkoor R., Piirsoo A., Saks V., Seppet E. Distinct organization of energy metabolism in HL-1 cardiac cell line and cardiomyocytes. Biochim. Biophys. Acta 2008, 1777:514-524.
30. Fukuda N., Fujita H., Fujita T., Ishiwata S. Regulatory roles of MgADP and calcium in tension development of skinned cardiac muscle. J. Muscle Res. Cell Motil. 1998, 19:909-921.
31. Fuller E.O., Goldberg D.I., Starnes J.W., Sacks L.M., Delivoria-Papadopoulos M. Mitochondrial respiration following acute hypoxia in the perfused rat heart. J. Mol. Cell. Cardiol. 1985, 17:71-81.
32. Gellerich F.N. The role of adenylate kinase in dynamic compartmentation of adenine nucleotides in the mitochondrial intermembrane space. FEBS Lett. 1992, 297:55-58.
33. Gellerich F.N., Schlame M., Bohnensack R., Kunz W. Dynamic compartmentation of adenine nucleotides in the mitochondrial intermembrane space of rat-heart mitochondria. Biochim. Biophys. Acta 1987, 890:117-126.
34. Gellerich F.N., Trumbeckaite S., Hertel K., Zierz S., Müller-Werdan U., Werdan K., Redl H., Schlag G. Impaired energy metabolism in hearts of septic baboons: diminished activities of complex I and complex II of the mitochondrial respiratory chain. Shock 1999, 11:336-341.
35. Gellerich F.N., Gizatullina Z., Trumbeckaite S., Nguyen H.P., Pallas T., Arandarcikaite O., Vielhaber S., Seppet E., Striggow F. The regulation of OXPHOS by extramitochondrial calcium. Biochim. Biophys. Acta 2010, 1797:1018-1027.
36. 2+ regulates the energization of isolated brain mitochondria by formation of pyruvate through the malate-aspartate shuttle. Biochem. J. 2012, 443:747-755.
37. Greiser M., Neuberger H.-R., Harks E., El-Armouche A., Boknik P., de Haan S., Verheyen F., Verheule S., Schmitz W., Ravens U., Nattel S., Allessie M.A., Dobrev D., Schotten U. Distinct contractile and molecular differences between two goat models of atrial dysfunction: AV block-induced atrial dilatation and atrial fibrillation. J. Mol. Cell. Cardiol. 2009, 46:385-394.
38. Henry W.L., Morganroth J., Pearlman A.S., Clark C.E., Redwood D.R., Itscoitz S.B., Epstein S.E. Relation between echocardiographically determined left atrial size and atrial fibrillation. Circulation 1976, 53:273-279.
39. Humphrey C.D., Pittman F.E. A simple methylene blue-azure II-basic fuchsin stain for epoxy-embedded tissue sections. Stain. Technol. 1974, 49:9-14.
40. Kammermeier H., Roeb E., Jüngling E., Meyer B. Regulation of systolic force and control of free energy of ATP-hydrolysis in hypoxic hearts. J. Mol. Cell. Cardiol. 1990, 22:707-713.
41. Knight Z.A., Shokat K.M. Features of selective kinase inhibitors. Chem. Biol. 2005, 12:621-637.
42. Kuznetsov A.V., Tiivel T., Sikk P., Kaambre T., Kay L., Daneshrad Z., Rossi A., Kadaja L., Peet N., Seppet E., Saks V.A. Striking differences between the kinetics of regulation of respiration by ADP in slow-twitch and fast-twitch muscles in vivo. Eur. J. Biochem. 1996, 241:909-915.
43. Laky D., Parascan L., Cândea V. Atrial structural remodeling in patients with atrial chronic fibrillations and in animal models. Rom. J. Morphol. Embryol. 2011, 52:95-98.
44. Lang R.M., Bierig M., Devereux R.B., Flachskampf F.A., Foster E., Pellikka P.A., Picard M.H., Roman M.J., Seward J., Shanewise J., Solomon S., Spencer K.T., St John Sutton M., Stewart W. Recommendations for chamber quantification. Eur. J. Echocardiogr. 2006, 7:79-108.
45. Laterveer F.D., Gellerich F.N., Nicolay K. Macromolecules increase the channeling of ADP from externally associated hexokinase to the matrix of mitochondria. Eur. J. Biochem. 1995, 232:569-577.
46. Liao X.D., Wang X.H., Jin H.J., Chen L.Y., Chen Q. Mechanical stretch induces mitochondria-dependent apoptosis in neonatal rat cardiomyocytes and G2/M accumulation in cardiac fibroblasts. Cell Res. 2004, 14:16-26.
47. Maguire J.J., Davies K.J., Dallman P.R., Packer L. Effects of dietary iron deficiency of iron-sulfur proteins and bioenergetic functions of skeletal muscle mitochondria. Biochim. Biophys. Acta 1982, 679:210-220.
48. Mary-Rabine L., Albert A., Pham T.D., Hordof A., Fenoglio J.J., Malm J.R., Rosen M.R. The relationship of human atrial cellular electrophysiology to clinical function and ultrastructure. Circ. Res. 1983, 52:188-199.
49. Mihm M.J., Yu F., Carnes C.A., Reiser P.J., McCarthy P.M., Van Wagoner D.R., Bauer J.A. Impaired myofibrillar energetics and oxidative injury during human atrial fibrillation. Circulation 2001, 104:174-180.
50. Miyamoto S., Murphy A.N., Brown J.H. Akt mediates mitochondrial protection in cardiomyocytes through phosphorylation of mitochondrial hexokinase-II. Cell Death Differ. 2008, 15:521-529.
51. Moorjani N., Westaby S., Narula J., Catarino P.A., Brittin R., Kemp T.J., Narula N., Sugden P.H. Effects of left ventricular volume overload on mitochondrial and death-receptor-mediated apoptotic pathways in the transition to heart failure. Am. J. Cardiol. 2009, 103:1261-1268.
52. Mosteller R.D. Simplified calculation of body-surface area. N. Engl. J. Med. 1987, 317:1098.
53. Narolska N.A., Eiras S., van Loon R.B., Boontje N.M., Zaremba R., Spiegelen Berg S.R., Stooker W., Huybregts M.A.J.M., Visser F.C., van der Velden J., Stienen G.J.M. Myosin heavy chain composition and the economy of contraction in healthy and diseased human myocardium. J. Muscle Res. Cell Motil. 2005, 26:39-48.
54. Nattel S., Burstein B., Dobrev D. Atrial remodeling and atrial fibrillation: mechanisms and implications. Circ. Arrhythm. Electrophysiol. 2008, 1:62-73.
55. Neuberger H.-R., Schotten U., Verheule S., Eijsbouts S., Blaauw Y., van Hunnik A., Allessie M. Development of a substrate of atrial fibrillation during chronic atrioventricular block in the goat. Circulation 2005, 111:30-37.
56. Ong S.-B., Hausenloy D.J. Mitochondrial morphology and cardiovascular disease. Cardiovasc. Res. 2010, 88:16-29.
57. Pastorino J.G., Hoek J.B. Regulation of hexokinase binding to VDAC. J. Bioenerg. Biomembr. 2008, 40:171-182.
58. Pastorino J.G., Hoek J.B., Shulga N. Activation of glycogen synthase kinase 3β disrupts the binding of hexokinase II to mitochondria by phosphorylating voltage-dependent anion channel and potentiates chemotherapy-induced cytotoxicity. Cancer Res. 2005, 65:10545-10554.
59. Peirson S.N., Butler J.N., Foster R.G. Experimental validation of novel and conventional approaches to quantitative real-time PCR data analysis. Nucleic Acids Res. 2003, 31:e73.
60. Perry C.G.R., Kane D.A., Lin C.-T., Kozy R., Cathey B.L., Lark D.S., Kane C.L., Brophy P.M., Gavin T.P., Anderson E.J., Neufer P.D. Inhibiting myosin-ATPase reveals a dynamic range of mitochondrial respiratory control in skeletal muscle. Biochem. J. 2011, 437:215-222.
61. Psaty B.M., Manolio T.A., Kuller L.H., Kronmal R.A., Cushman M., Fried L.P., White R., Furberg C.D., Rautaharju P.M. Incidence of and risk factors for atrial fibrillation in older adults. Circulation 1997, 96:2455-2461.
62. Reiser P.J., Portman M.A., Ning X.H., Schomisch Moravec C. Human cardiac myosin heavy chain isoforms in fetal and failing adult atria and ventricles. Am. J. Physiol. Heart Circ. Physiol. 2001, 280:H1814-H1820.
63. Rosca M.G., Vazquez E.J., Kerner J., Parland W., Chandler M.P., Stanley W., Sabbah H.N., Hoppel C.L. Cardiac mitochondria in heart failure: decrease in respirasomes and oxidative phosphorylation. Cardiovasc. Res. 2008, 80:30-39.
64. Rosca M., Minkler P., Hoppel C.L. Cardiac mitochondria in heart failure: normal cardiolipin profile and increased threonine phosphorylation of complex IV. Biochim. Biophys. Acta 2011, 1807:1373-1382.
65. Rostovtseva T.K., Bezrukov S.M. VDAC inhibition by tubulin and its physiological implications. Biochim. Biophys. Acta 2012, 1818:1526-1535.
66. Schefe J.H., Lehmann K.E., Buschmann I.R., Unger T., Funke-Kaiser H. Quantitative real-time RT-PCR data analysis: current concepts and the novel "gene expression's CT difference" formula. J. Mol. Med. 2006, 84:901-910.
67. Scheubel R.J., Tostlebe M., Simm A., Rohrbach S., Prondzinsky R., Gellerich F.N., Silber R.E., Holtz J. Dysfunction of mitochondrial respiratory chain complex I in human failing myocardium is not due to disturbed mitochondrial gene expression. J. Am. Coll. Cardiol. 2002, 40:2174-2181.
68. Schotten U., Neuberger H.R., Allessie M.A. The role of atrial dilatation in the domestication of atrial fibrillation. Prog. Biophys. Mol. Biol. 2003, 82:151-162.
69. Schwertz H., Carter J.M., Abdudureheman M., Russ M., Buerke U., Schlitt A., Müller-Werdan U., Prondzinsky R., Werdan K., Buerke M. Myocardial ischemia/reperfusion causes VDAC phosphorylation which is reduced by cardioprotection with a p38 MAP kinase inhibitor. Proteomics 2007, 7:4579-4588.
70. Seppet E.K., Kaambre T., Sikk P., Tiivel T., Vija H., Tonkonogi M., Sahlin K., Kay L., Appaix F., Braun U., Eimre M., Saks V.A. Functional complexes of mitochondria with Ca, MgATPases of myofibrils and sarcoplasmic reticulum in muscle cells. Biochim. Biophys. Acta 2001, 1504:379-395.
71. Seppet E.K., Eimre M., Anmann T., Seppet E., Peet N., Käämbre T., Paju K., Piirsoo A., Kuznetsov A.V., Vendelin M., Gellerich F.N., Zierz S., Saks V.A. Intracellular energetic units in healthy and diseased hearts. Exp. Clin. Cardiol. 2005, 10:173-183.
72. Seppet E., Eimre M., Peet N., Paju K., Orlova E., Ress M., Kõvask S., Piirsoo A., Saks V.A., Gellerich F.N., Zierz S., Seppet E.K. Compartmentation of energy metabolism in atrial myocardium of patients undergoing cardiac surgery. Mol. Cell. Biochem. 2005, 270:49-61.
73. Seppet E.K., Eimre M., Anmann T., Seppet E., Piirsoo A., Peet N., Paju K., Guzun R., Beraud N., Pelloux S., Tourneur Y., Kuznetsov A.V., Käämbre T., Sikk P., Saks V.A. Structure-function relationships in the regulation of energy transfer between mitochondria and ATPases in cardiac cells. Exp. Clin. Cardiol. 2006, 11:189-194.
74. Sheldon K.L., Maldonado E.N., Lemasters J.J., Rostovtseva T.K., Bezrukov S.M. Phosphorylation of voltage-dependent anion channel by serine/threonine kinases governs its interaction with tubulin. PLoS One 2011, 6:e25539.
75. Southworth R., Davey K.A.B., Warley A., Garlick P.B. A reevaluation of the roles of hexokinase I and II in the heart. Am. J. Physiol. Heart Circ. Physiol. 2007, 292:H378-H386.
76. Sun L., Shukair S., Naik T.J., Moazed F., Ardehali H. Glucose phosphorylation and mitochondrial binding are required for the protective effects of hexokinases I and II. Mol. Cell. Biol. 2008, 28:1007-1017.
77. Terman A., Kurz T., Navratil M., Arriaga E.A., Brunk U.T. Mitochondrial turnover and aging of long-lived postmitotic cells: the mitochondrial-lysosomal axis theory of aging. Antioxid. Redox Signal. 2010, 12:503-535.
78. Thiedemann K.U., Ferrans V.J. Left atrial ultrastructure in mitral valvular disease. Am. J. Pathol. 1977, 89:575-604.
79. Thijssen V.L., Ausma J., Borgers M. Structural remodelling during chronic atrial fibrillation: act of programmed cell survival. Cardiovasc. Res. 2001, 52:14-24.
80. Trumbeckaite S., Opalka J.R., Neuhof C., Zierz S., Gellerich F.N. Different sensitivity of rabbit heart and skeletal muscle to endotoxin-induced impairment of mitochondrial function. Eur. J. Biochem. 2001, 268:1422-1429.
81. Trumbeckaite S., Neuhof C., Zierz S., Gellerich F.N. Calpain inhibitor (BSF 409425) diminishes ischemia/reperfusion-induced damage of rabbit heart mitochondria. Biochem. Pharmacol. 2003, 65:911-916.
82. Vannier C., Veksler V., Mekhfi H., Mateo P., Ventura-Clapier R. Functional tissue and developmental specificities of myofibrils and mitochondria in cardiac muscle. Can. J. Physiol. Pharmacol. 1996, 74:23-31.
83. Vaziri S.M., Larson M.G., Benjamin E.J., Levy D. Echocardiographic predictors of nonrheumatic atrial fibrillation. The Framingham Heart Study. Circulation 1994, 89:724-730.
84. Wakili R., Yeh Y.-H., Yan Qi X., Greiser M., Chartier D., Nishida K., Maguy A., Villeneuve L.-R., Boknik P., Voigt N., Krysiak J., Kääb S., Ravens U., Linke W.A., Stienen G.J.M., Shi Y., Tardif J.-C., Schotten U., Dobrev D., Nattel S. Multiple potential molecular contributors to atrial hypocontractility caused by atrial tachycardia remodeling in dogs. Circ. Arrhythm. Electrophysiol. 2010, 3:530-541.
85. Wang J., Bai L., Li J., Sun C., Zhao J., Cui C., Han K., Liu Y., Zhuo X., Wang T., Liu P., Fan F., Guan Y., Ma A. Proteomic analysis of mitochondria reveals a metabolic switch from fatty acid oxidation to glycolysis in the failing heart. Sci. China Ser. C Life Sci. 2009, 52:1003-1010.
86. Watson T., Shantsila E., Lip G.Y.H. Mechanisms of thrombogenesis in atrial fibrillation: Virchow's triad revisited. Lancet 2009, 373:155-166.
87. Wittig I., Carrozzo R., Santorelli F.M., Schägger H. Supercomplexes and subcomplexes of mitochondrial oxidative phosphorylation. Biochim. Biophys. Acta 2006, 1757:1066-1072.
88. WMA World Medical Association Declaration of Helsinki. Recommendations guiding physicians in biomedical research involving human subjects. Cardiovasc. Res. 1997, 35:2-3.
89. Yeih D.-F., Yeh H.-I., Lin L.-Y., Tsay Y.-G., Chiang F.-T., Tseng C.-D., Tseng Y.-Z. Enhanced activity and subcellular redistribution of myocardial hexokinase after acute myocardial infarction. Int. J. Cardiol. 2011, 149:74-79.
90. Zor T., Selinger Z. Linearization of the Bradford protein assay increases its sensitivity: theoretical and experimental studies. Anal. Biochem. 1996, 236:302-308.
91. Zuurbier C.J., Eerbeek O., Meijer A.J. Ischemic preconditioning, insulin, and morphine all cause hexokinase redistribution. Am. J. Physiol. Heart Circ. Physiol. 2005, 289:H496-H499.
92. Zuurbier C.J., Smeele K.M.A., Eerbeek O. Mitochondrial hexokinase and cardioprotection of the intact heart. J. Bioenerg. Biomembr. 2009, 41:181-185.